|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_ocn777549432 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
120221s2011 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCO
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d D6H
|d OCLCO
|d AGLDB
|d OCLCO
|d OCLCA
|d VNS
|d OCLCQ
|d VTS
|d TOF
|d OCLCO
|d REC
|d OCLCO
|d STF
|d OCLCO
|d AU@
|d OCLCQ
|d K6U
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781611222746
|q (electronic bk.)
|
| 020 |
|
|
|a 1611222745
|q (electronic bk.)
|
| 020 |
|
|
|z 9781611226508
|
| 020 |
|
|
|z 1611226503
|
| 029 |
1 |
|
|a DEBBG
|b BV043169767
|
| 029 |
1 |
|
|a DEBSZ
|b 421479574
|
| 035 |
|
|
|a (OCoLC)777549432
|
| 050 |
|
4 |
|a RC280.B8
|b H467 2011eb
|
| 060 |
|
4 |
|a QZ 202
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/44906
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a HER2 and cancer :
|b mechanism, testing, and targeted therapy /
|c Sophie I. Williams and Christopher E. Rogers, editors.
|
| 260 |
|
|
|a New York :
|b Nova Science,
|c ©2011.
|
| 300 |
|
|
|a 1 online resource (xii, 245 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer etiology, diagnosis and treatments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Targeting HER2 with photodynamic therapy / Ján Koval [and others] -- Investigating molecular mechanisms of specificity in regulation of the HER2 receptor tyrosine kinase through molecular modeling and simulation / Shannon E. Telesco [and others] -- The HER2 shedding and its consequences on breast cancer / Pierre-Jean Lamy, Anne-Sophie Gauchez, Chantal Tse -- The role of HERr2 in targeted cancer therapy and hypothesized future perspectives / Luca Monfregola, Stefania De Luca -- HER2 positive primary breast cancer in older women : clinical significance and therapeutic challenge / B.M. Syed [and others] -- Influence of psychological stress on initiation, progression, metastasis in breast cancer / Ming Shi [and others] -- Development of trastuzumab resistance : is it only in signaling? / Timothy Kute, John Stehle -- Targeted nanomedicines conjugated with HER2 antibodies in cancer therapy / Jie Gao [and others] -- Topoisomerase II-alpha index predicts the efficacy of anthracycline-based chemotherapy for breast cancers / Kiyomi Taniyama [and others] -- Role of 16HER2 splice variant in breast tumor progression and response to HER2-targeted therapy / Serenella M. Pupa [and others] -- Molecular profiling of HER2-related protein networks in formalin-fixed and paraffin-embedded cancer tissues / Daniela Berg, Karl-Friedrich Becker -- Trastuzumab : clinical evidence for the first targeted therapy in breast cancer / Ronan Glynn -- Influence of HER2 on individual treatment for breast cancer / Takashi Ishikawa -- Prognostic value of HER2 in primary breast tumors smaller than 1 cm / Joachim Rom -- HER2 and cancer / Christian Singer.
|
| 588 |
0 |
|
|a Print version record.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Breast
|x Cancer
|x Genetic aspects.
|
| 650 |
|
0 |
|a HER-2 gene.
|
| 650 |
|
0 |
|a HER-2 protein.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
2 |
|a Receptor, ErbB-2
|
| 650 |
|
2 |
|a Genes, erbB-2
|
| 650 |
|
6 |
|a Sein
|x Cancer
|x Aspect génétique.
|
| 650 |
|
6 |
|a Gène HR2.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a Breast
|x Cancer
|x Genetic aspects.
|2 fast
|0 (OCoLC)fst00838278
|
| 650 |
|
7 |
|a HER-2 gene.
|2 fast
|0 (OCoLC)fst00949827
|
| 650 |
|
7 |
|a HER-2 protein.
|2 fast
|0 (OCoLC)fst00949828
|
| 700 |
1 |
|
|a Williams, Sophie I.
|
| 700 |
1 |
|
|a Rogers, Christopher E.
|
| 776 |
0 |
8 |
|i Print version:
|t HER2 and cancer.
|d New York : Nova Science, ©2011
|z 9781611226508
|w (DLC) 2010048854
|w (OCoLC)693560744
|
| 830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=411412
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018898
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 411412
|
| 994 |
|
|
|a 92
|b IZTAP
|
